Brooks Automation CEO Stephen Schwartz's 2019 pay rises 1% to $4M
Brooks Automation reports 2019 executive compensation
By ExecPay News
Published: December 17, 2019
Brooks Automation reported fiscal year 2019 executive compensation information on December 17, 2019.
In 2019, six executives at Brooks Automation received on average a compensation package of $2.1M, a 1% decrease compared to previous year.
Average pay of disclosed executives at Brooks Automation
Stephen S. Schwartz, Chief Executive Officer, received $4M in total, which increased by 1% compared to 2018. 75% of Schwartz's compensation, or $3M, was in stock awards. Schwartz also received $299K in non-equity incentive plan, $668K in salary, as well as $13K in other compensation.
For fiscal year 2019, the median employee pay was $49,619 at Brooks Automation. Therefore, the ratio of Stephen S. Schwartz's pay to the median employee pay was 80 to one.
Lindon G. Robertson, Chief Financial Officer, received a compensation package of $2.2M, which increased by 2% compared to previous year. 68% of the compensation package, or $1.5M, was in stock awards.
Maurice H. Tenney III, Former President, Brooks Life Sciences, earned $2M in 2019, a 17% increase compared to previous year.
Guojuan Liao, President, GENEWIZ, Inc, received $1.7M in 2019.
David E. Jarzynka, President, Brooks Semiconductor Solutions Group, earned $1.5M in 2019, a 2% increase compared to previous year.
David C. Gray, Senior Vice President, Chief Strategy and New Business Officer , received $1.1M in 2019, which decreases by 8% compared to 2018.
Brooks Automation's fiscal year ends on September 30.
Related executives
Stephen Schwartz
Brooks Automation
Chief Executive Officer
Lindon Robertson
Brooks Automation
Chief Financial Officer
Guojuan Liao
Brooks Automation
President, GENEWIZ, Inc
David Jarzynka
Brooks Automation
President, Brooks Semiconductor Solutions Group
David Gray
Brooks Automation
Senior Vice President, Chief Strategy and New Business Officer
Maurice Tenney
Brooks Automation
Former President, Brooks Life Sciences
You may also like
Source: SEC filing on December 17, 2019.